Nearly 40% of men and women will be diagnosed with cancer at some point in their lives. Treatment innovation in this area is critical to fighting the disease.

In an effort to understand these emerging trends, we asked prescribers to share their thoughts on chimeric antigen receptor T cell therapy, also known as CAR T-cell. In our new webinar, prescribers will provide their perceptions on awareness, knowledge and promise. We will review the latest CAR T-cell research finding and examine prescriber sentiments towards autologous and allogeneic CAR-T. Webinar participants will learn more about:

  • Historical context for CAR T-cell as a therapeutic approach
  • Prescriber perspectives on CAR T-cell awareness, treatment and expectations
  • U.S. hematologists’ and oncologists’ analysis of autologous vs. allogeneic CAR-T